article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive.

Pharma 210
article thumbnail

AbbVie CEO looks like a fool before Congress

World of DTC Marketing

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. Why the increase?

Pharma 181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S.

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

Because nearly all prescriptions are now written electronically. The Point of Care Marketing Association (POCMA) is the Go-to Source for POC Education/Advocacy Founded in 2013, POCMA supports the POC channel through education and advocacy. And to do that in today’s digital age, you’ve got to think “EHR.”

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end. The post How retailers and “payviders” are disrupting U.S.

Retail 52
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

In 2013, this changed when an NIH lab reported the structure of the RSV protein, leading to the exploration of the RSV structure in ways that were not previously possible. The post Race to the finish: pharma edges closer to approval with RSV vaccines appeared first on Pharmaceutical Technology.

Pharma 64
article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

More FDC products flowing into pharma pipelines. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Replacing two or three pills with a single FDC drug product also translates into less time spent filling (and refilling) prescriptions. The numbers tell the story.